Rhythm Pharmaceuticals Inc banner

Wall St Price Targets

RYTM Price Forecast
Based on 19 analysts

+58% Upside
from $92.4 today

Rhythm Pharmaceuticals Inc (RYTM)’s 12-month stock price forecast through November 2027 has a consensus target of $145.86, implying 58% upside. The forecast is based on price targets from 19 Wall Street analysts.

RYTM Analyst Rating
Based on 19 analysts

avg. 4.53 of 5
Strong buy
12 63%
Buy
5 26%
Hold
2 11%
Sell
0 0%
Strong sell
0 0%

Analysts rate RYTM Strong buy, with 17 of 19 recommending Buy or Strong buy.

Rhythm Pharmaceuticals Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is RYTM's stock price target?
Price Target
145.86 USD

According to Wall Street analysts, the average 1-year price target for RYTM is 145.86 USD with a low forecast of 121.2 USD and a high forecast of 168 USD.

What is the Revenue forecast for Rhythm Pharmaceuticals Inc?
Projected CAGR
41%

The compound annual growth rate for Revenue over the next 8 years is 41%.

What is the Gross Profit forecast for Rhythm Pharmaceuticals Inc?
Projected CAGR
51%

The compound annual growth rate for Gross Profit over the next 6 years is 51%.

Back to Top